Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Catalyst Pharmaceuticals Inc    CPRX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/13/2017 01/17/2017 01/18/2017 01/19/2017 01/20/2017 Date
1.24(c) 1.23(c) 1.22(c) 1.2(c) 1.19(c) Last
1 007 835 562 998 364 197 322 740 348 657 Volume
+5.08% -0.81% -0.81% -1.64% -0.83% Change
More quotes
Financials ($)
Sales 2016 -
EBIT 2016 -20,6 M
Net income 2016 -19,8 M
Debt 2016 -
Yield 2016 -
Sales 2017 -
EBIT 2017 -24,6 M
Net income 2017 -24,5 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 0
Capi. / Sales2017 0
Capitalization 99,6 M
More Financials
Company
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company.It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder.The... 
More about the company
Surperformance© ratings of Catalyst Pharmaceuticals I
Trading Rating : Investor Rating : -
More Ratings
Latest news on CATALYST PHARMACEUTICALS I
01/20 CATALYST PHARMACEUTICALS (NASDAQ : CPRX) Offering Novel Therapies for Rare Disea..
2016 CATALYST PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits..
2016 Catalyst Pharmaceuticals Announces First Patient Enrolled in Second Phase 3 T..
2016 CATALYST PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits..
2016 Catalyst Pharmaceuticals Provides Update on its Clinical Trial for Patients w..
2016 CATALYST PHARMACEUTICALS : to Participate in the 28th Annual Piper Jaffray Healt..
2016 CATALYST PHARMACEUTICALS, INC. (NASD : CPRX) Files An 8-K Announces Third Quarte..
2016 CATALYST PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits..
2016 Catalyst Pharmaceuticals Announces Third Quarter 2016 Financial Results and P..
2016 CATALYST PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CON..
More news
Sector news : Bio Therapeutic Drugs
01/13DJNOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs
01/12 Investors in big pharma, biotech look to ride out Trump storm
01/12DJHot Stocks to Watch in the U.S. and Canada
01/09 Regeneron CEO says Amgen not putting patients first in patent dispute
01/09DJCELGENE : Anticipates Slowing Sales Growth for Main Drug Revlimid
More sector news : Bio Therapeutic Drugs
Latest Tweets
01/20Catalyst Pharmaceuticals (NASDAQ: CPRX) Offering Novel Therapies for Rare Dis.. 
01/20$CPRX Offering Novel Therapies for Rare Diseases  
01/20$CPRX Offering Novel Therapies for Rare Diseases  
01/20$CPRX Offering Novel Therapies for Rare Diseases  
01/20$CPRX Offering Novel Therapies for Rare Diseases  
More tweets
Qtime:63
News from SeekingAlpha
01/04 CATALYST PHARMACEUTICALS : Why This $1 Biotech Stock Is A Strong Buy For 2017
2016 Midday Gainers / Losers
2016 Enrollment underway in Catalyst Pharma's second late-stage study of Firdapse ..
2016 Catalyst Pharmaceutical Partners' (CPRX) CEO Patrick McEnany on Q3 2016 Resul..
2016 Catalyst Pharmaceutical beats by $0.01
Advertisement
Chart CATALYST PHARMACEUTICALS I
Duration : Period :
Catalyst Pharmaceuticals I Technical Analysis Chart | CPRX | US14888U1016 | 4-Traders
Full-screen chart
Technical analysis trends CATALYST PHARMACE...
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 4,38 $
Spread / Average Target 265%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Patrick J. McEnany Chairman, President & Chief Executive Officer
Steven R. Miller Chief Operating & Scientific Officer
Alicia Grande Chief Financial Officer, Treasurer & VP
Gary Ingenito Chief Medical Officer & Head-Regulatory Affairs
Philip H. Coelho Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CATALYST PHARMACEUTICA..13.33%100
AMGEN, INC.5.79%114 415
GILEAD SCIENCES, INC.-0.84%94 290
CELGENE CORPORATION-2.67%88 079
REGENERON PHARMACEUTIC..-1.23%38 329
ACTELION LTD4.58%24 308
More Results